Improve your erection quality with Bocox™
The quality of your erection depends primarily on blood flow to the penis. When you’re aroused, blood rushes into your penis, allowing you to engage in sexual activities and intercourse. Erection problems usually occur when blood circulation to the penis slows down, making it hard for you to achieve and maintain erections. Effective treatments for erectile dysfunction act by improving blood flow to penile capillaries. Bocox™ injections target the root cause of erectile dysfunction to improve blood flow to the penis.
What is Bocox™
Bocox™ is a minimally invasive treatment that involves injecting 100 units of Botox into the corpus cavernosum of the penis — 50 units on each side of the muscle. Botox injections cause temporary relaxation of the corpus cavernosum muscles, thus allowing the penis to fill with blood more effectively. It blocks the nerve signals that usually constrict these muscles.
This is an off label use that is not FDA approved but supported by a large published Belgian review of its use (see below) and by additional published peer reviewed studies.
Bocox™ can improve the following:
Inability to maintain erections
Length and girth of the penis
Overall sexual function
Benefits of Bocox™:
Minimally invasive treatment
Minimal discomfort during the treatment
Safe and effective procedure
Suitable alternative to the P-shot
Improves overall erection quality
Improves self-esteem and confidence
Minimal side effects
No post-treatment downtime
Intra-Cavernosal Injection of Botulinum Toxin in the Treatment of Erectile Dysfunction: a Systematic Review and Meta-Analysis
Objective: To evaluate the role of botulinum toxin in treating erectile dysfunction as a novel treatment strategy avoiding morbid and irreversible surgeries.
Methods: A systematic review of literature was conducted from January 1990 through July 31, 2021. Search engines used included PubMed, Embase and Medline databases, to identify studies investigating botulinum toxin in erectile dysfunction, published in English. Seven studies in total were included in our review including two pre-clinical studies. A meta-analysis was performed on three outcomes included commonly in at least two studies. Among the different parameters assessed were, Erection Hardness Score (EHS), Peak Systolic Velocity in cavernosal artery (PSV) and the Sexual Health Inventory for Men (SHIM) score.
Results: A clear benefit was noted for intracavernosal injection (ICI) of botulinum toxin (BoNT-A) on PSV with a mean difference (MD) of 10.82 [4.99, 16.65] and a heterogeneity of I2=61%. EHS results favored BoNT-A as well over placebo with a MD of 0.7 [0.47, 0.93] and heterogeneity of I2=94%. As for SHIM score, with a heterogeneity of I2=85%, no statistically significant difference was found (MD 0.58 [-0.03, 1.20]).
Conclusion: Our review and meta-analysis have shown statistical significance for the benefit of BoNT-A in terms of EHS and PSV. However, this statistical significance should be interpreted in light of the given limitations: small sample size, heterogeneity in data collection, patient selection bias, and clinical significance of the measured differences. ICI of BoNT-A should currently be limited to clinical studies to further elucidate its clinical benefit.
The Bocox™ Procedure is a specific method of using Botox® to improve penis health & function. It has been shown in research to help erectile dysfunction (ED) for some men--even when Viagra & Cialis does not work.
Nothing, including this procedure, works for everyone. Discuss the procedure with your provider & read the consent form which incorporates the possible side effects seen with both Botox and Viagra (since, in theory, the same side effects could occur with Bocox™).WARNING: Treating erectile dysfunction is serious business; only providers trained & licensed by the Cellular Medicine Association® (indicated by their listing on our directory) can legally use the name, Bocox™, to describe a procedure offered in their office.